IQVIA Holdings Operating Income 2011-2024 | IQV
- IQVIA Holdings operating income for the quarter ending September 30, 2024 was $0.550B, a 14.35% increase year-over-year.
- IQVIA Holdings operating income for the twelve months ending September 30, 2024 was $2.077B, a 11.97% increase year-over-year.
- IQVIA Holdings annual operating income for 2023 was $1.977B, a 9.89% increase from 2022.
- IQVIA Holdings annual operating income for 2022 was $1.799B, a 29.15% increase from 2021.
- IQVIA Holdings annual operating income for 2021 was $1.393B, a 90.56% increase from 2020.
IQVIA Holdings Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $1,977 |
2022 | $1,799 |
2021 | $1,393 |
2020 | $731 |
2019 | $777 |
2018 | $741 |
2017 | $665 |
2016 | $576 |
2015 | $646 |
2014 | $590 |
2013 | $462 |
2012 | $396 |
2011 | $345 |
2010 | $395 |
IQVIA Holdings Quarterly Operating Income (Millions of US $) |
|
---|---|
2024-09-30 | $550 |
2024-06-30 | $520 |
2024-03-31 | $506 |
2023-12-31 | $501 |
2023-09-30 | $481 |
2023-06-30 | $524 |
2023-03-31 | $471 |
2022-12-31 | $379 |
2022-09-30 | $472 |
2022-06-30 | $453 |
2022-03-31 | $495 |
2021-12-31 | $463 |
2021-09-30 | $302 |
2021-06-30 | $286 |
2021-03-31 | $342 |
2020-12-31 | $289 |
2020-09-30 | $187 |
2020-06-30 | $62 |
2020-03-31 | $193 |
2019-12-31 | $166 |
2019-09-30 | $204 |
2019-06-30 | $197 |
2019-03-31 | $210 |
2018-12-31 | $207 |
2018-09-30 | $181 |
2018-06-30 | $170 |
2018-03-31 | $183 |
2017-12-31 | $142 |
2017-09-30 | $195 |
2017-06-30 | $126 |
2017-03-31 | $202 |
2016-12-31 | $79 |
2016-09-30 | $168 |
2016-06-30 | $150 |
2016-03-31 | $179 |
2015-12-31 | $177 |
2015-09-30 | $167 |
2015-06-30 | $158 |
2015-03-31 | $143 |
2014-12-31 | $159 |
2014-09-30 | $149 |
2014-06-30 | $141 |
2014-03-31 | $141 |
2013-12-31 | $127 |
2013-09-30 | $125 |
2013-06-30 | $95 |
2013-03-31 | $115 |
2012-12-31 | $94 |
2012-09-30 | $109 |
2012-06-30 | $101 |
2012-03-31 | $92 |
2011-12-31 | |
2010-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $36.625B | $14.984B |
IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $202.706B | 24.73 |
Intuitive Surgical (ISRG) | United States | $193.352B | 101.09 |
Alcon (ALC) | Switzerland | $43.519B | 29.12 |
Edwards Lifesciences (EW) | United States | $41.599B | 26.42 |
IDEXX Laboratories (IDXX) | United States | $35.273B | 41.54 |
DexCom (DXCM) | United States | $30.978B | 46.65 |
Waters (WAT) | United States | $22.985B | 33.99 |
STERIS (STE) | Ireland | $21.603B | 24.87 |
SONOVA HOLDING (SONVY) | Switzerland | $20.257B | 0.00 |
Hologic (HOLX) | United States | $17.928B | 19.36 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $13.368B | 13.72 |
Sysmex ADR (SSMXY) | Japan | $13.192B | 41.37 |
Globus Medical (GMED) | United States | $11.424B | 28.93 |
Penumbra (PEN) | United States | $9.397B | 92.04 |
Masimo (MASI) | United States | $9.192B | 44.48 |
Teleflex (TFX) | United States | $9.024B | 14.39 |
Glaukos (GKOS) | United States | $7.669B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $5.015B | 0.00 |
Integer Holdings (ITGR) | United States | $4.655B | 26.38 |
Veracyte (VCYT) | United States | $3.419B | 102.61 |
Inari Medical (NARI) | United States | $3.051B | 0.00 |
TransMedics (TMDX) | United States | $2.857B | 90.57 |
LivaNova (LIVN) | United Kingdom | $2.839B | 16.39 |
Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
Elekta AB (EKTAY) | Sweden | $2.209B | 19.86 |
Tandem Diabetes Care (TNDM) | United States | $2.135B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
RxSight (RXST) | United States | $1.848B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.284B | 0.00 |
Artivion (AORT) | United States | $1.242B | 82.28 |
OPKO Health (OPK) | United States | $1.044B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.901B | 15.31 |
Paragon 28 (FNA) | United States | $0.864B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.738B | 0.00 |
IRadimed (IRMD) | United States | $0.682B | 36.87 |
Mesa Laboratories (MLAB) | United States | $0.660B | 15.55 |
AxoGen (AXGN) | United States | $0.641B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
SiBone (SIBN) | United States | $0.561B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.547B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
Semler Scientific (SMLR) | United States | $0.503B | 29.61 |
Tactile Systems Technology (TCMD) | United States | $0.446B | 24.14 |
Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
CVRx (CVRX) | United States | $0.377B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
NeuroPace (NPCE) | United States | $0.337B | 0.00 |
AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
Inogen (INGN) | United States | $0.241B | 0.00 |
Accuray (ARAY) | United States | $0.216B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
Nevro (NVRO) | United States | $0.160B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.160B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.140B | 15.02 |
Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
908 Devices (MASS) | United States | $0.100B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
LENSAR (LNSR) | United States | $0.088B | 0.00 |
InspireMD (NSPR) | Israel | $0.080B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
Hyperfine (HYPR) | United States | $0.073B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.058B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.056B | 0.00 |
Envoy Medical (COCH) | United States | $0.046B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
Spectral AI (MDAI) | United States | $0.041B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
Neuronetics (STIM) | United States | $0.034B | 0.00 |
Precision Optics (POCI) | United States | $0.031B | 0.00 |
DarioHealth (DRIO) | United States | $0.026B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.026B | 0.00 |
NexGel (NXGL) | United States | $0.023B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
PAVmed (PAVM) | United States | $0.012B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
Tenon Medical (TNON) | United States | $0.007B | 0.00 |
Nuwellis (NUWE) | United States | $0.006B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Avinger (AVGR) | United States | $0.003B | 0.00 |
Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Venus Concept (VERO) | Canada | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |